Adverse Events Time to Event

This report displays the cumulative incidence of adverse events leading to discontinuation of study treatment.

Report Results Description

Running this report with the Nicardipine sample setting generates the tabbed Results shown below.

This report presents a plot and several tables.

Cumulative Incidence Plot

This plot shows the cumulative incidence of adverse events over the time elapsed from the first treatment dose. Examination of this plot enables one to see when the events occurred and gives an accurate estimate of the incidence by treatment group. Subjects are censored at the date of the last disposition record unless another date is chosen.

Tables

Tables provide basic statistics for each treatment group and for the overall study. The table below shows the results for the Nicardipine treatment group.

The tables list time from the first dose and, at each time point, both survival in the trial and failure to continue, absolute number failed or censored and the number remaining at risk.

Options

Data

End Date Variable to Use for Censoring

Use the End Date Variable to Use for Censoring option for specifying the end date for censoring. Options include the reference end date, date of the last treatment, or the date of the last disposition record (selected by default).

Time Scale

Use this widget to specify the time scale to use for times. Options include Hours, Days, Weeks, Months, and Years. Refer to Time Scale for more information

General and Drill Down Buttons

Action buttons, provide you with an easy way to drill down into your data. The following action buttons are generated by this report:

Click to rerun the report using default settings.
Click to view the associated data tables. Refer to Show Tables/View Data for more information.
Click to generate a standardized pdf- or rtf-formatted report containing the plots and charts of selected sections.
Click to generate a JMP Live report. Refer to Create Live Report for more information.
Click to take notes, and store them in a central location. Refer to Add Notes for more information.
Click to read user-generated notes. Refer to View Notes for more information.
Click to open and view the Review Subject Filter.
Click to specify Derived Population Flags that enable you to divided the subject population into two distinct groups based on whether they meet very specific criteria.

Note: For information about how treatment emergent adverse events (TEAEs) are defined in JMP Clinical, please refer to How does JMP Clinical determine whether an Event Is a Treatment Emergent Adverse Event?.

Default Settings

Refer to Set Study Preferences for default Subject Level settings.

Methodology

Adverse events leading to treatment discontinuation are determined from the adverse event dataset where the action taken variable (AEACN) contains "Withdrawn". If there are multiple treatments administered, then all action taken variables are scanned for at least one containing "Withdrawn". Subjects with missing censor date information are removed from the analysis. Notes are displayed at the top of the report for what censor date variable is used and how many subjects were removed due to missing censor date information.